Long-term administration of hesperidin (HES) or glucosyl hesperidin (GHES), a water-soluble analogue of HES, brings about an antihypertensive effect on spontaneously hypertensive rats (SHR). In the present study, we investigated the effects of long-term admin istration of HES and GHES (corresponding to 30mg/d/kg body weight) on serum lipid con centration and morphology of vasculature. Serum HDL cholesterol increased in both SHR and Wistar-Kyoto rats (WKY) fed a HES-or GHES-containing diet for 25wk. Simulta neously, GHES administration reduced the vascular diameter and media-intimal cross-sec tional area of the abdominal aorta in SHR. These results suggest that HES as well as GHES improves serum cholesterol composition and that GHES inhibits hypertrophy in vasculature as well.
The characteristics of the contraction of vascular smooth muscle were examined in thoracic aorta and ischiadic artery of chickens aged 3, 6, 10 and 18 weeks. High K+ solution induced a sustained contraction in smooth muscle preparations of aorta and ischiadic artery in vitro. The contraction of the ischiadic artery became greater with age, whereas the contraction of the aortic preparation did not. In the ischiadic artery, the magnitude of the contraction divided by the weight of the muscle preparation was constant at all ages studied. However, those in the aortic preparation decreased with age. These results suggest that the changes in the contractile responses of vascular smooth muscle owing to the age of chickens vary widely according to the preparations of blood vessels, and that the functional smooth muscle cells in the thoracic aorta of chicken do not increase with age.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.